Nanocellulose-Based Biomedical Scaffolds in Future Bioeconomy : A Techno-Legal Assessment of the State-of-the-Art
Copyright © 2022 Mishra, Pavelek, Rasticova, Mishra and Ekielski..
Nanocellulose is a broader term used for nano-scaled cellulosic crystal and/or fibrils of plant or animal origin. Where bacterial nanocellulose was immediately accepted in biomedicine due to its "cleaner" nature, the plant-based nanocellulose has seen several roadblocks. This manuscript assesses the technological aspects (chemistry of cellulose, nanocellulose producing methods, its purity, and biological properties including toxicity and suggested applications in final drug formulation) along with legal aspects in REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals) regulation by the European Union, EMA (European Medicine Agency). The botanical biomass processing methods leading to the nanoscale impurity (lignin and others) on nanocellulose surface, along with surface modification with harsh acid treatments are found to be two major sources of "impurity" in botanical biomass derived nanocellulose. The status of nanocellulose under the light of REACH regulation along with EMA has been covered. The provided information can be directly used by material and biomedical scientists while developing new nanocellulose production strategies as well as formulation design for European markets.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
Frontiers in bioengineering and biotechnology - 9(2021) vom: 01., Seite 789603 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mishra, Pawan Kumar [VerfasserIn] |
---|
Links: |
---|
Themen: |
Bioeconomy |
---|
Anmerkungen: |
Date Revised 01.03.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3389/fbioe.2021.789603 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM337552762 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM337552762 | ||
003 | DE-627 | ||
005 | 20231225234658.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3389/fbioe.2021.789603 |2 doi | |
028 | 5 | 2 | |a pubmed24n1125.xml |
035 | |a (DE-627)NLM337552762 | ||
035 | |a (NLM)35223812 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mishra, Pawan Kumar |e verfasserin |4 aut | |
245 | 1 | 0 | |a Nanocellulose-Based Biomedical Scaffolds in Future Bioeconomy |b A Techno-Legal Assessment of the State-of-the-Art |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 01.03.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2022 Mishra, Pavelek, Rasticova, Mishra and Ekielski. | ||
520 | |a Nanocellulose is a broader term used for nano-scaled cellulosic crystal and/or fibrils of plant or animal origin. Where bacterial nanocellulose was immediately accepted in biomedicine due to its "cleaner" nature, the plant-based nanocellulose has seen several roadblocks. This manuscript assesses the technological aspects (chemistry of cellulose, nanocellulose producing methods, its purity, and biological properties including toxicity and suggested applications in final drug formulation) along with legal aspects in REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals) regulation by the European Union, EMA (European Medicine Agency). The botanical biomass processing methods leading to the nanoscale impurity (lignin and others) on nanocellulose surface, along with surface modification with harsh acid treatments are found to be two major sources of "impurity" in botanical biomass derived nanocellulose. The status of nanocellulose under the light of REACH regulation along with EMA has been covered. The provided information can be directly used by material and biomedical scientists while developing new nanocellulose production strategies as well as formulation design for European markets | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Bioeconomy | |
650 | 4 | |a Biomedicine | |
650 | 4 | |a Cellulose | |
650 | 4 | |a EMA | |
650 | 4 | |a Nanocellulose | |
650 | 4 | |a REACh regulation | |
700 | 1 | |a Pavelek, Ondrej |e verfasserin |4 aut | |
700 | 1 | |a Rasticova, Martina |e verfasserin |4 aut | |
700 | 1 | |a Mishra, Harshita |e verfasserin |4 aut | |
700 | 1 | |a Ekielski, Adam |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Frontiers in bioengineering and biotechnology |d 2013 |g 9(2021) vom: 01., Seite 789603 |w (DE-627)NLM240045297 |x 2296-4185 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2021 |g day:01 |g pages:789603 |
856 | 4 | 0 | |u http://dx.doi.org/10.3389/fbioe.2021.789603 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 9 |j 2021 |b 01 |h 789603 |